Ligand id: 8735

Name: avelumab

Compound class Antibody
Approved drug? Yes (EMA & FDA (2017))
International Nonproprietary Names
INN number INN
10062 avelumab
Bavencio® | MSB-0010718C | MSB0010718C
Avelumab is a programmed death-ligand 1 (PD-L1; CD274) blocking human IgG1 lambda monoclonal antibody . It is the first drug approved for the treatment of Merkel cell carcinoma (MCC).
Peptide sequence and structural information for this antibody are available from its IMGT/mAb-db record.
Database Links
Specialist databases
IMGT/mAb-DB 512
Other databases
GtoPdb PubChem SID 252827393
Search PubMed clinical trials avelumab
Search PubMed titles avelumab
Search PubMed titles/abstracts avelumab